David C Rubinsztein

Dr. David C Rubinsztein

Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BKBrian W. Kunkle
Brian W. Kunkle
T(The European Alzheimer’s Disease Initiative (Eadi)
The European Alzheimer’s Disease Initiative (Eadi)
BGBenjamin Grenier-Boley
Benjamin Grenier-Boley
RSRebecca Sims
Rebecca Sims
JBJoshua C. Bis
Joshua C. Bis
MPMargaret A. Pericak-Vance
Margaret A. Pericak-Vance

31 August 2012 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
PDF file
David C RubinszteinDavid C Rubinsztein
David C Rubinsztein
PCPatrice Codogno
Patrice Codogno
BLBeth Levine
Beth Levine

1 March 2017 in Neuron
Verified
Journal Article
Closed access
FMFiona M. Menzies
Fiona M. Menzies
AFAngeleen Fleming
Angeleen Fleming
ACAndrea Caricasole
Andrea Caricasole
CBCarla F. Bento
Carla F. Bento
SAStephen P. Andrews
Stephen P. Andrews
David C RubinszteinDavid C Rubinsztein
David C Rubinsztein

1 February 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SSSovan Sarkar
Sovan Sarkar
JDJanet E. Davies
Janet E. Davies
ZHZebo Huang
Zebo Huang
ATAlan Tunnacliffe
Alan Tunnacliffe
David C RubinszteinDavid C Rubinsztein
David C Rubinsztein
Trehalose, a disaccharide present in many non-mammalian species, protects cells against various environmental stresses. Whereas some of the protective effects may be explained by its chemical chaperone properties, its actions are largely unknown. Here we report a novel function of trehalose as an mTOR-independent autophagy activator. Trehalose-induced autophagy enhanced the clearance of autophagy substrates like mutant huntingtin and the A30P and A53T mutants of α-synuclein, associated with Huntington disease (HD) and Parkinson disease (PD), respectively. Furthermore, trehalose and mTOR inhibition by rapamycin together exerted an additive effect on the clearance of these aggregate-prone proteins because of increased autophagic activity. By inducing autophagy, we showed that trehalose also protects cells against subsequent pro-apoptotic insults via the mitochondrial pathway. The dual protective properties of trehalose (as an inducer of autophagy and chemical chaperone) and the combinatorial strategy with rapamycin may be relevant to the treatment of HD and related diseases, where the mutant proteins are autophagy substrates.

17 July 2017 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
RSRebecca Sims
Rebecca Sims
SLSven J van der Lee
Sven J van der Lee
ANAdam C Naj
Adam C Naj
CBCéline Bellenguez
Céline Bellenguez
NBNandini Badarinarayan
Nandini Badarinarayan
GSGerard D Schellenberg
Gerard D Schellenberg

13 March 2011 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
VKViktor Korolchuk
Viktor Korolchuk
SSShinji Saiki
Shinji Saiki
MLMaike Lichtenberg
Maike Lichtenberg
FSFarah H. Siddiqi
Farah H. Siddiqi
EREsteban A. Roberts
Esteban A. Roberts
David C RubinszteinDavid C Rubinsztein
David C Rubinsztein
The subcellular position of lysosomes, whether adjacent to the plasma membrane or perinuclear, regulates mTOR signalling and autophagy in response to nutrient availablity. Lysosomal position is regulated by changes in intracellular pH. mTOR (mammalian target of rapamycin) signalling and macroautophagy (henceforth autophagy) regulate numerous pathological and physiological processes, including cellular responses to altered nutrient levels. However, the mechanisms regulating mTOR and autophagy remain incompletely understood. Lysosomes are dynamic intracellular organelles1,2 intimately involved both in the activation of mTOR complex 1 (mTORC1) signalling and in degrading autophagic substrates3,4,5,6,7,8. Here we report that lysosomal positioning coordinates anabolic and catabolic responses with changes in nutrient availability by orchestrating early plasma-membrane signalling events, mTORC1 signalling and autophagy. Activation of mTORC1 by nutrients correlates with its presence on peripheral lysosomes that are physically close to the upstream signalling modules, whereas starvation causes perinuclear clustering of lysosomes, driven by changes in intracellular pH. Lysosomal positioning regulates mTORC1 signalling, which in turn influences autophagosome formation. Lysosome positioning also influences autophagosome–lysosome fusion rates, and thus controls autophagic flux by acting at both the initiation and termination stages of the process. Our findings provide a physiological role for the dynamic state of lysosomal positioning in cells as a coordinator of mTORC1 signalling with autophagic flux.